India  
 
NewsR.in

FDA, EU diverge on AstraZeneca COVID-19 vaccine

Video Credit: Reuters Studio - Duration: 01:42s - Published
FDA, EU diverge on AstraZeneca COVID-19 vaccine

FDA, EU diverge on AstraZeneca COVID-19 vaccine

The Food and Drug Administration widened its probe into a serious illness linked to halted clinical trials for AstraZeneca's potential COVID-19 vaccine, sources told Reuters, while in Europe the vaccine approval process has been put on the fast track.

Conway G.

Gittens reports.


You Might Like


Related videos from verified sources

Daily Covid-19 Minute: Astrazeneca’s Vaccine Trial Has Been On Pause For 6 Weeks, Here’s What We Know [Video]

Daily Covid-19 Minute: Astrazeneca’s Vaccine Trial Has Been On Pause For 6 Weeks, Here’s What We Know

Some good news in our race for a COVID-19 vaccine. Both Johnson & Johnson and Astrazeneca have announced they’re resuming phase 3 trials for their respective COVID vaccines.

Credit: CBS 62 Detroit     Duration: 01:08Published
AstraZeneca Covid-19 Vaccine Trial Showing Promising Results [Video]

AstraZeneca Covid-19 Vaccine Trial Showing Promising Results

AstraZeneca's Covid-19 vaccine trial has shown promise producing antibodies in adult and elderly patients, a sign that a viable vaccine could be ready by year-end.

Credit: The Street     Duration: 02:03Published
Coronavirus Pandemic: Oxford Covid Vaccine brings hope for the elderly | Oneindia News [Video]

Coronavirus Pandemic: Oxford Covid Vaccine brings hope for the elderly | Oneindia News

Giving hope to the elderly battling against the Coronavirus Pandemic, early test results for a coronavirus vaccine being developed by the University of Oxford show that it produces a robust immune..

Credit: Oneindia     Duration: 01:24Published